Italia markets open in 8 hours 41 minutes

Biofrontera AG (0DOL.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
1,1500-1,2406 (-51,89%)
Alla chiusura: 01:25PM BST
Schermo intero
Chiusura precedente2,3906
Aperto1,1500
Denaro0,0000 x N/D
Lettera0,0000 x N/D
Min-Max giorno1,1500 - 1,1500
Intervallo di 52 settimane1,1500 - 1,1500
Volume2.691
Media VolumeN/D
Capitalizzazione50,863M
Beta (5 anni mensile)1,54
Rapporto PE (ttm)4,29
EPS (ttm)0,2680
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Biofrontera AG decides to delist ADS from Nasdaq to reduce complexity and costs

    Leverkusen, Germany, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera AG (the “Company”) (Nasdaq: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, decided today its American Depositary Shares (“ADS”) should be delisted from the Nasdaq Capital Market (“Nasdaq”) and its reporting obligations with the Securities and Exchange Commission (“SEC”) should be deregistered and terminated. The main purpose of the delisting is to reduce complexity in financial reporting and adm

  • GlobeNewswire

    Biofrontera AG announces mediation results

    Leverkusen, Germany, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (ISIN: DE0006046113) has been in mediation proceedings with Mr. Wilhelm K. T. Zours and Deutsche Balaton AG for a year in order to find a solution for the settlement of legal disputes and other differences (see ad hoc announcement of September 11, 2020). Mr. Zours is an indirect major shareholder of Biofrontera AG, holding the shares in Biofrontera AG through various companies (her

  • GlobeNewswire

    Biofrontera reports financial results for the third quarter and nine months ended September 30, 2021

    Leverkusen, Germany, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the nine months ended September 30, 2021. Key financial figures and business performance for the nine months ended September 30, 2021 In EUR thousands9M 20219M 2020ChangeQ3 2021Q3 2020ChangeRevenue18,473 20,829 (11)%5,379 4,713 14%thereof from product sales18,473 14,337 29%5,379 4,